IN BRIEF: Belluscura notes share price rise, says no news since Friday

Belluscura - London-based medical device developer - Notes the jump in share price movement. Says ...

Alliance News 13 May, 2025 | 1:01PM
Email Form Facebook Twitter LinkedIn RSS

Belluscura - London-based medical device developer - Notes the jump in share price movement. Says there have been no notifiable developments since its update on Friday, when it announced the start of a strategic review to "strengthen its capital position" in a bid to generate sufficient working capital. Further, that day the company provided some colour on current trading, noting renewed and robust demand for the X-PLOR portable oxygen solution during April, resulting in a record sales month of USD520,000. This was despite challenges in late February and March in sourcing product. Finally, also on Friday, Belluscura said the full commercial launch of the DISCOV-R respiratory support device remained on track and is expected towards the end of the third quarter, and that the US import tariff on its portable oxygen containers remains at zero.

Current stock price: 1.45 pence each, up 41% on Tuesday afternoon in London

12-month change: down 86%

By Tom Budszus, Alliance News slot editor

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Belluscura PLC Ordinary Shares 1.07 GBX 9.74 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures